Division of Advanced Cardiac Imaging, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Section of Nuclear Medicine and Diagnostic Imaging, Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
Int J Cardiol. 2018 May 15;259:222-226. doi: 10.1016/j.ijcard.2018.02.060. Epub 2018 Feb 16.
There is growing concern about radiation exposure from nuclear myocardial perfusion imaging (MPI), particularly among younger patients who are more prone to develop untoward effects of ionizing radiation, and hence US and European professional society guidelines recommend age as a consideration in weighing radiation risk from MPI. We aimed to determine how patient radiation doses from MPI vary across age groups in a large contemporary international cohort.
Data were collected as part of a global cross-sectional study of centers performing MPI coordinated by the International Atomic Energy Agency (IAEA). Sites provided information on each MPI study completed during a single week in March-April 2013. We compared across age groups laboratory adherence to pre-specified radiation-related best practices, radiation effective dose (ED; a whole-body measure reflecting the amount of radiation to each organ and its relative sensitivity to radiation's deleterious effects), and the proportion of patients with ED ≤ 9 mSv, a target level specified in guidelines.
Among 7911 patients undergoing MPI in 308 laboratories in 65 countries, mean ED was 10.0 ± 4.5 mSv with slightly higher exposure among younger age groups (trend p value < 0.001). There was no difference in the proportion of patients with ED ≤ 9 mSv across age groups, or in adherence to best practices based on the median age of patients in a laboratory.
In contemporary nuclear cardiology practice, the age of the patient appears not to impact protocol selection and radiation dose, contrary to professional society guidelines.
人们越来越关注核心肌灌注成像(MPI)带来的辐射暴露问题,尤其是在更易受到电离辐射不良影响的年轻患者中,因此美国和欧洲专业学会指南建议在权衡 MPI 的辐射风险时,应将年龄作为一个考虑因素。我们旨在确定在一个大型国际当代队列中,MPI 患者的辐射剂量如何随年龄组而变化。
该数据作为国际原子能机构(IAEA)协调的一项针对进行 MPI 的中心的全球横断面研究的一部分收集。各中心提供了 2013 年 3 月至 4 月期间一周内完成的每一项 MPI 研究的信息。我们比较了不同年龄组之间实验室对辐射相关最佳实践的遵守情况、辐射有效剂量(ED;反映每个器官接受的辐射量及其对辐射有害影响的相对敏感性的全身衡量标准)以及 ED≤9mSv 的患者比例(指南中指定的目标水平)。
在 65 个国家的 308 个实验室的 7911 名患者中,ED 的平均值为 10.0±4.5mSv,年轻年龄组的暴露略高(趋势 p 值<0.001)。不同年龄组的 ED≤9mSv 的患者比例或基于实验室中患者的中位数年龄的最佳实践的遵守情况无差异。
与专业学会指南相反,在当代核心脏病学实践中,患者的年龄似乎不会影响方案选择和辐射剂量。